Introduction
============

Malaria is a parasitic disease which is caused in human mainly by five species of *Plasmodium*, called *P. falciparum,P. vivax, P. malariae, P. ovale* spp., and *P. knowlesi*([@B1]). Almost all species of human malaria parasites have a similar life cycle consists of sexual phase of multiplications, which occurs in specific species of Anopheline mosquitoes and an asexual phase of multiplications (schizogony) which take places in blood cells of the vertebrate host which might follow with invasion to the liver cells ([@B2]).

Malaria estimated annual incidence rate is about 219 million people worldwide and still considered as one of the most important public health problems especially in children of the poorest parts of the world. Currently, more than 40% of the world's population are at risk of malaria and the annual mortality is about 1 million ([@B3]). Although more than 50 years ago the worldwide malaria eradication program was endorsed but yet high mortality and morbidity caused by malaria especially *P. falciparum* (WHO: World Malaria Report, 2013), studies in different aspects of the disease are highly encouraged. Every available approach should be used to design safe and effective anti-*malaria* drugs ([@B4]-[@B6]).

Regardless of global efforts to develop an effective vaccine against malaria and valuable publications yet no vaccine is available against malaria ([@B7], [@B8]).

Current epidemiological and treatment situations of malaria urge to use different approaches to develop new tools for malaria treatment ([@B9]). The rate of drug resistance in malaria is high ([@B3]), drug resistance in malaria defined as when the parasite survive or multiply, regardless of administration of enough dose of the drug which is absorbed (WHO technical report series, 1965). The speed of development of new anti-*malaria* drugs should be faster than rapid spread of drug resistance. In drug development it should be considered that each stage of malaria life cycle shows susceptibility to a specific anti-*malaria* drug so development of several drugs might be needed to control the disease ([@B10]).

Quantitative Structure Activity Relationship (QSAR) and Quantitative Structure Toxicity Relationship (QSTR) models are mathematical equations relating the chemical structure of a substance to the ‎biological activity and toxicity, respectively ([@B11]-[@B21]). The current QSAR models are developed based on the resistant malarial strains TM90-C2B (chloroquine, mefloquine, pyrimethamine, and atovaquone resistant) and for cytotoxicity against J774 mammalian of a set of ‎‎28, quinolone derivatives which have already synthesized ([@B22]). To select the set of descriptors that are more relevant to EC~50~ of the desired compounds, MLR models were built and QSAR and QSTR equations with stepwise selection and ‎elimination of variables were established using SPSS and Matlab software.‎

Experimental
============

*QSAR and QSTR equations*

The biological data used in this study were anti-*malaria* activities (EC~50~), and cytotoxicity of 28 quinolone derivatives against multidrug resistant *p. falciparum*(TM90-C2B) and J774 mammalian, respectively (21).

As reported previously structures of desired compounds 1 to 28 ([Table 1](#T1){ref-type="table"}) were built and optimized using HyperChem software (version 7, Hypercube Inc.) ([@B11]-[@B15]). A large number of molecular descriptors were calculated using HyperChem ([Table 2](#T2){ref-type="table"}) and Dragon software ([@B23], [@B24]). Dragon software was used to calculate different functional groups, topological, geometrical, and constitutional descriptors for each molecule. The calculated descriptors were collected in a data matrix wherein the number of rows and columns were the number of molecules and descriptors, respectively. Some of the chemical parameters including molecular volume (V), molecular surface area (SA approx), surface area (SA grid) hydrophobicity (LogP), hydration energy (HE), refractivity (Rf), molecular polarizability (MP) and different quantum chemical descriptors including dipole moment (DM) and the highest occupied molecular orbital (HOMO) energies are shown in [Table 2](#T2){ref-type="table"}.

Briefly, after removing the constant or near-constant descriptors to decrease the redundancy existed in the descriptor data matrix, the correlation of descriptors with each other and with the activity and cytotoxicity (pEC~50~) of the molecules were examined and collinear descriptors (*i.e.* r\>0.9) were detected. Among the collinear descriptors, the one which shows the highest correlation with activity or cytotoxicity was retained and the others were removed from the data matrix. To select the set of descriptors that were most relevant to the anti-*malaria* activities (pEC~50~) and cytotoxicity, MLR models were built and the QSAR equations with stepwise selection and elimination of variables were established using MLR method (25). SPSS (version 18) and Matlab (version 7.6.0, R2008a) software were used for MLR regression method ([@B11]-[@B16]).

In the case of each regression problem, SPSS produced many models and were ranked based on standard error of calibration and coefficient of multiple determinations, wherein some models had a large number of input variables and thus they were over-fitted. To hinder obtaining over-fitted models, the generated QSAR and QSTR models were validated by the leave-one out cross-validation procedure to check the predictability and robustness. A balance between the high cross-validation correlation coefficient and low number of descriptors were used as the criterion for model selection. The overall prediction abilities of the final models were assessed by using a prediction set containing about 25% of the original molecules. To do so, the data set of activity was randomly classified to calibrate and predict the sets. The model coefficients were calculated using calibration data and then were used to calculate the anti-*malaria* activities of the molecules in the prediction set.

###### 

The chemical structure of quinolone derivatives.

  --
  --

###### 

Calculated properties of quinolones using the HyperChem software.

  **Compound**   **surface area(approx)**   **Surface area(grid)**   **volume**   **hydration energy**   **log p**   **refractivity**   **polarizability**   **dipolemoment**   **homo** [a](#TFN1){ref-type="table-fn"}
  -------------- -------------------------- ------------------------ ------------ ---------------------- ----------- ------------------ -------------------- ------------------ ------------------------------------------
  1              637.07                     685.75                   1152.78      -5.72                  3.75        109.05             42.11                5.62               -8.78
  2              396.06                     426.22                   680.98       -4.82                  1           64.46              24.52                5.99               -8.77
  3              604.95                     661                      1104.66      -5.19                  3.73        105.21             40.19                4.83               -8.59
  4              655.37                     701.42                   1195.12      -4.02                  4.4         114.17             43.86                4.54               -8.49
  5              558.7                      617.37                   1030.75      -6.36                  3.26        100.13             38.45                5.12               -8.53
  6              559.69                     618.08                   1038.63      -5.65                  3.21        100.37             38.35                4.50               -8.46
  7              567.72                     625.52                   1058.52      -7.67                  2.49        101.79             38.99                5.43               -8.32
  8              467.8                      492.18                   804.34       -3.95                  1.85        75.43              28.79                6.72               -8.49
  9              501.99                     522.28                   860.37       -8.9                   1.25        80.74              30.62                7.21               -8.50
  10             685.09                     701.64                   1184.64      -3.18                  2.75        108.96             41.8                 4.75               -8.53
  11             526.28                     586.18                   996.12       -3.42                  1.28        96.67              36.7                 6.69               -8.49
  12             566.98                     559.29                   925.33       -1.81                  1.62        87.6               33.17                6.1                -8.47
  13             565.79                     623.43                   1047.37      -6.24                  3.54        102.95             39.14                5.13               -8.66
  14             622.7                      724.29                   1261.99      -2.88                  3.63        129.01             48.91                6.65               -8.48
  15             528.2                      595.95                   989.94       -7.03                  2.74        95.33              36.52                4.65               -8.56
  16             668.81                     760.73                   1303.62      -6.27                  5.22        129.66             49.85                4.63               -8.47
  17             656.24                     754.64                   1289.86      -7.81                  4.84        127.44             49.14                6.38               -8.66
  18             656.41                     753.56                   1292.28      -7.71                  4.84        127.44             49.14                6.00               -8.6
  19             731.13                     804.68                   1381.12      -5.7                   6.1         135.64             51.41                7.57               -8.72
  20             745.17                     826.25                   1407.73      -7.76                  6.9         137.24             52.05                6.54               -8.61
  21             782.61                     885.75                   1550.89      -9.31                  6.79        156.12             60.06                5.84               -8.55
  22             885.15                     988.68                   1707.67      -10.05                 8.43        168.31             64.18                5.87               -8.56
  23             864.51                     974.07                   1697.37      -10.26                 8.8         168.52             64.18                5.51               -8.59
  24             748.7                      828.23                   1430.31      -5.03                  6.57        140.68             53.25                7.41               -8.79
  25             731.04                     814.43                   1400.7       -4.35                  6.16        139.75             53.52                4.39               -8.55
  26             735.48                     815.64                   1393.25      -5.51                  6.24        135.85             51.32                7.15               -8.78
  27             724.51                     808.52                   1391.1       -5.15                  6.21        139.51             53.61                5.39               -8.64
  28             683.76                     773.38                   1333.12      -9.05                  3.83        131.6              49.97                6.73               -8.67

highest occupied molecular orbital.

Results and Discussion
======================

*QSAR equation*

Based on the procedure explained in the Materials and Methods section, using a stepwise multiple linear regression method, the following five-parametric equation 1 (Equation 1) was derived for quinolones 1 to 28.

In the QSAR and QSTR equations, n is the number of data points, R2 is the correlation coefficient, S is the standard deviation, F is the Fisher's F-value and q2 is the leave-one-out (LOO) cross validated coefficient that was obtained by a multiple linear regression.

The anti-*malaria* activities of the quinolone derivatives were tested against multidrug resistant *P. falciparum* (TM90-C2B). Herewith, we explain QSAR model for anti-*malaria* activity against TM90-C2B and cytotoxicity against the J774 mammalian in equations 1 and 2, respectively.

Equation (1):

pEC~50~= (-18.1 ± 9.02) -- (8.8 ± 1.7) PJI2 -- (12.99 ± 8.18) Mv + (29.6 ± 3.58) PCR -- (0.68 ± 0.11) nBM + (0.03 ± 0.006) VAR

n=28, F=33.157, R^2^=0.92, S=0.89, p\<0.000, q^2^=0.71

Equation 1 explains 92% of the variance in pEC~50~ data wherein the relative error prediction (REP) of the equation is shown in Table 5. This equation describes the effect of PJI2, Mv, PCR, nBM and VAR indices on the anti TM90-c2B activity. The PJI2 and VAR are among topological descriptors and Mv and nBM are among constitutional descriptors. PCR is among walk and path counts descriptor that show ratio of multiple path count over path count.

Equation 1 indicates that PCR and VAR demonstrate positive contribution and PJI2, Mv, and nBM show a negative contribution towards the anti-*malaria*activities. Comparison of the coefficient of descriptors reveals that anti-*malaria* (TM90-c2B) activities might be affected mainly by PCR, Mv, and PJI2 with 29.6, 12.99 and 8.8 values, respectively. The calculated pEC~50~ using equation 1 is presented in [Table 3](#T3){ref-type="table"} and the graphical representation of cross validated calculated activity and the experimental values using equation 1 are presented in [Figure 1](#F1){ref-type="fig"}. The correlation coefficient matrix for the descriptors that were used in the MLR equation 1 is shown in [Table 4](#T4){ref-type="table"}. Based on the equation 1, in order to design a new ligand with high potency, substitutions with high amount of PCR and low amounts of Mv and PJI2 should be considered.

###### 

Anti-*malaria* activity of quinolones.

  **Number**   [a](#TFN2){ref-type="table-fn"} **pEC**~50~**Exp.**   [b](#TFN3){ref-type="table-fn"} **pEC**~50~**Calc**   [c](#TFN4){ref-type="table-fn"} **\|REP\|**
  ------------ ----------------------------------------------------- ----------------------------------------------------- ---------------------------------------------
  1            3.9208                                                3.86037                                               0.0157
  2            1.1163                                                1.41986                                               0.2138
  3            2.3556                                                4.94160                                               0.5233
  4            4.8239                                                4.59390                                               0.0500
  5            2.1421                                                2.19951                                               0.0261
  6            2.5575                                                2.45931                                               0.0399
  7            2.70996                                               3.33258                                               0.1868
  8            2.0985                                                2.30913                                               0.0912
  9            1.1101                                                1.36155                                               0.1846
  10           0.2125                                                0.43881                                               0.5156
  11           1.1391                                                1.11276                                               0.0236
  12           1.21896                                               0.83808                                               0.4545
  13           2.3615                                                2.06961                                               0.1410
  14           2.0376                                                1.4404                                                0.4146
  15           2.1469                                                1.56789                                               0.3693
  16           1.1169                                                1.19209                                               0.0631
  17           0.9931                                                1.19209                                               0.1669
  18           1.2306                                                1.19209                                               0.0323
  19           0.6108                                                0.6373                                                0.0415
  20           0.6003                                                0.3849                                                0.5597
  21           0.9991                                                1.23954                                               0.1939
  22           0.3925                                                1.16511                                               0.6631
  23           1.3233                                                1.48233                                               0.1073
  24           1.8539                                                1.95589                                               0.0522
  25           0.7878                                                1.27179                                               0.3805
  26           2.5100                                                1.82599                                               0.3746
  27           1.2660                                                1.14189                                               0.1087
  28           1.8928                                                0.528                                                 2.5848

The experimentally activity (pEC~50~) in TM90-C2B.

The calculated pEC~50~ using multi linear regression equation 1.

The absolute value of Percent of the relative error of prediction.

###### 

Pearson correlation coefficient matrix for the descriptors of quinolone used in the MLR activity equation 1.

  **Correlations**                                                            
  --------------------- --------- -------- -------- -------- ------- -------- --------
                        pEC~50~   PJI2     Mv       PCR      nBM     VAR      
  Pearson Correlation   pEC~50~   1.000    -0.514   -0.209   0.183   -0.226   -0.290
  PJI2                  -0.514    1.000    -0.377   -0.135   0.140   0.305    
  Mv                    -0.209    -0.377   1.000    0.367    0.405   0.236    
  PCR                   0.183     -0.135   0.367    1.000    0.833   0.649    
  nBM                   -0.226    0.140    0.405    0.833    1.000   0.935    
  VAR                   -0.290    0.305    0.236    0.649    0.935   1.000    
  Sig. (1-tailed)       pEC~50~   .        0.003    0.143    0.176   0.123    0.067
  PJI2                  0.003     .        0.024    0.247    0.239   0.057    
  Mv                    0.143     0.024    .        0.027    0.016   0.113    
  PCR                   0.176     0.247    0.027    .        0.000   0.000    
  nBM                   0.123     0.239    0.016    0.000    .       0.000    
  VAR                   0.067     0.057    0.113    0.000    0.000   .        
  N                     pEC~50~   28       28       28       28      28       28
  PJI2                  28        28       28       28       28      28       
  Mv                    28        28       28       28       28      28       
  PCR                   28        28       28       28       28      28       
  nBM                   28        28       28       28       28      28       
  VAR                   28        28       28       28       28      28       

![Plot of cross-validated calculated activity of TM90-C2B obtained by QSAR equation 1.](ijpr-14-775-g002){#F1}

*QSTR equation*

Based on the procedure explained in the Materials and Methods section, using a stepwise multiple linear regression method, the following three-parametric equation 2 was derived for quinolones 1 to 28.

Equation (2):

pEC~50~= (-7.35± 0.657) + (22.5 ± 1.46) MSD + (0.815 ± 0.085) MAXDP -- (0.097 ± 0.014) X1sol

n=18, F=81.14, R^2^=0.96, S=0.049, p\<0.000, q2=0.812

Equation 2 explains 96% of the variance in pEC~50~ data which describes the effect of MSD, MAXDP and X1sol indices on cytotoxicity. MSD and MAXDP are among topological descriptors and X1sol is among connectivity indices. The relative error prediction (REP) of the equation 2 is shown in [Table 5](#T5){ref-type="table"}.

Equation 2 indicates that MSD and MAXDP demonstrate positive contribution and X1sol show a negative contribution towards the cytotoxicity which all descriptors have positive concept, so comparison of the coefficient of descriptors reveals that which cytotoxicity might be affected mainly by MSD. The calculated pEC~50~ using equation 2 is presented in [Table 5](#T5){ref-type="table"} and the graphical representation of cross validated calculated activities and the experimental values using equation 2 are presented in [Figure 2](#F2){ref-type="fig"}. The correlation coefficient matrix for the descriptors that were used in the MLR equation 2 is shown in [Table 6](#T6){ref-type="table"}. Based on this equation in order to have a new ligand with low cytotoxicity, some substitution with low amounts of MSD properties should be considered.

###### 

Cytotoxicity of quinolone in term of pEC~50~.

  **Number**   [a](#TFN5){ref-type="table-fn"} **pEC** ~50~ **Exp.**   [b](#TFN6){ref-type="table-fn"} **pEC** ~50~ **Calc.**   [c](#TFN7){ref-type="table-fn"} **\|REP\|**
  ------------ ------------------------------------------------------- -------------------------------------------------------- ---------------------------------------------
  1            1.337242                                                1.729347                                                 0.226736
  2            1.431798                                                1.490277                                                 0.039240
  3            1.552842                                                1.741733                                                 0.108450
  4            3                                                       1.736874                                                 0.727241
  5            1.721246                                                1.637286                                                 0.051280
  6            2.397940                                                2.237676                                                 0.071621
  7            1.638272                                                1.680007                                                 0.024842
  8            1.638272                                                1.675107                                                 0.021989
  9            1.638272                                                1.673392                                                 0.020987
  10           1.698970                                                1.645639                                                 0.032407
  11           1.698970                                                1.705242                                                 0.003678
  12           1.721246                                                1.812865                                                 0.050538
  13           1.795880                                                1.975504                                                 0.090926
  14           1.795880                                                1.811327                                                 0.008528
  15           1.698970                                                1.584743                                                 0.072079
  16           1.657577                                                1.640181                                                 0.010606
  17           1.721246                                                1.612183                                                 0.067649
  18           1.657577                                                1.5981                                                   0.037217

The experimentally cytotoxicity pEC~50~in J774.

The calculated pEC~50~ using multi linear regression equation 2.

The absolute value of Percent of the relative error of prediction**.**

###### 

Pearson correlation coefficient matrix for the descriptors of quinolones used in the MLR cytotoxicity equation 2.

  **Correlations**                                           
  --------------------- --------- -------- -------- -------- --------
                        pEC~50~   MSD      MAXDP    X1sol    
  Pearson Correlation   pEC~50~   1.000    0.379    -0.068   -0.043
  MSD                   0.379     1.000    -0.686   -0.484   
  MAXDP                 -0.068    -0.686   1.000    0.931    
  X1sol                 -0.043    -0.484   0.931    1.000    
  Sig. (1-tailed)       pEC~50~   .        0.060    0.394    0.432
  MSD                   0.060     .        0.001    0.021    
  MAXDP                 0.394     0.001    .        0.000    
  X1sol                 0.432     0.021    0.000    .        
  N                     pEC~50~   18       18       18       18
  MSD                   18        18       18       18       
  MAXDP                 18        18       18       18       
  X1sol                 18        18       18       18       

![Plot of cross-validated calculated activity of Cytotoxicity obtained by QSTR equation 2.](ijpr-14-775-g003){#F2}

Conclusion
==========

Twenty eight analogs of quinolone with anti-*malaria* activities were subjected to QSAR and QSTR studies in order to design new ligands with an improved therapeutic index. Based on our QSAR and QSTR equations (Equations 1 and 2) PJI2, Mv, PCR, nBM, and VAR can effect on anti-*malaria*activity and MSD, MAXDP, and X1sol can effect on cytotoxicity. Our QSAR and QSTR calculations reveals in order to increase the therapeutic index of the series of anti-*malaria* compounds, some moieties with high amount of PCR and low amounts of Mv, PJI2, and MSD should be considered in the lead compounds.
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